Triple negative breast cancer: looking for the missing link between biology and treatments

The so called “Triple Negative Breast Cancer” (TNBC) represents approximately 15-20% of breast cancers. This acronym simply means that the tumour does not express oestrogen receptor (ER) and progesterone receptor (PR) and does not exhibit amplification of the human epidermal growth factor receptor 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Palma, Giuseppe, Frasci, Giuseppe, Chirico, Andrea, Esposito, Emanuela, Siani, Claudio, Saturnino, Carmela, Arra, Claudio, Ciliberto, Gennaro, Giordano, Antonio, D’Aiuto, Massimiliano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694936/
https://www.ncbi.nlm.nih.gov/pubmed/26387133

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694936/
https://www.ncbi.nlm.nih.gov/pubmed/26387133

Ejemplares similares